G6PC1 and Insulin resistance: More recently, Kim al. found that the G6pc−/− mice treated with rAAV‐G6PC and rAAV‐co(codon‐optimized)‐G6PC expressed more than 3% of normal hepatic G6Pase‐α activity and prevented the development of age‐related obesity and insulin resistance.31, 87